|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oza AM, Tinker AV, Oaknin A,
Shapira-Frommer R, McNeish IA, Swisher EM, Ray-Coquard I,
Bell-McGuinn K, Coleman RL, O'Malley DM, et al: Antitumor activity
and safety of the PARP inhibitor rucaparib in patients with
high-grade ovarian carcinoma and a germline or somatic BRCA1 or
BRCA2 mutation: Integrated analysis of data from Study 10 and
ARIEL2. Gynecol Oncol. 147:267–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim G, Ison G, McKee AE, Zhang H, Tang S,
Gwise T, Sridhara R, Lee E, Tzou A, Philip R, et al: FDA approval
summary: Olaparib Monotherapy in patients with Deleterious Germline
BRCA-Mutated advanced ovarian cancer treated with three or more
lines of chemotherapy. Clin Cancer Res. 21:4257–4261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu L, Yu X, Zhang L, Ding X, Pan H, Wen X,
Xu S, Xing Y, Fan J, Ge S, et al: The long non-coding RNA RHPN1-AS1
promotes uveal melanoma progression. Int J Mol Sci. 18:2262017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu X, Lei Z, Wang Z, Xu Y, Liu C, Li P,
Wu H and Gong Z: Knockdown of LncRNA RHPN1-AS1 inhibits cell
migration, invasion and proliferation in head and neck squamous
cell carcinoma. J Cancer. 10:4000–4008. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui P, Su J, Li Q, Xu G and Zhu N: LncRNA
RHPN1-AS1 Targeting miR-625/REG3A promotes cell proliferation and
invasion of glioma cells. Onco Targets Ther. 12:7911–7921. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duan H, Li X, Chen Y, Wang Y and Li Z:
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and
migration in cervical cancer via the modulation of miR-299-3p/FGF2
axis. Life Sci. 239:1168562019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng S, Lv P, Su J, Miao K, Xu H and Li
M: Silencing of the long non-coding RNA RHPN1-AS1 suppresses the
epithelial-to-mesenchymal transition and inhibits breast cancer
progression. Am J Transl Res. 11:3505–3517. 2019.PubMed/NCBI
|
|
12
|
Zheng W, Li H, Zhang H, Zhang C, Zhu Z,
Liang H and Zhou Y: Long noncoding RNA RHPN1-AS1 promotes
colorectal cancer progression via targeting miR-7-5p/OGT axis.
Cancer Cell Int. 20:542020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fen H, Hongmin Z, Wei W, Chao Y, Yang Y,
Bei L and Zhihua S: RHPN1-AS1 drives the progression of
hepatocellular carcinoma via regulating miR-596/IGF2BP2 Axis. Curr
Pharm Des. 25:4630–4640. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding L, Wang L, Li Z, Jiang X, Xu Y and
Han N: The positive feedback loop of RHPN1-AS1/miR-1299/ETS1
accelerates the deterioration of gastric cancer. Biomed
Pharmacother. 124:1098482020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mattick JS: Non-coding RNAs: The
architects of eukaryotic complexity. EMBO Rep. 2:986–991. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Xu R and Li N: MicroRNAs from plants
to animals, do they define a new messenger for communication? Nutr
Metab (Lond). 15:682018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seok H, Ham J, Jang ES and Chi SW:
MicroRNA target recognition: Insights from Transcriptome-wide
non-canonical interactions. Mol Cells. 39:375–381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shao L, He Q, Liu Y, Liu X, Zheng J, Ma J,
Liu L, Li H, Li Z and Xue Y: UPF1 regulates the malignant
biological behaviors of glioblastoma cells via enhancing the
stability of Linc-00313. Cell Death Dis. 10:6292019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lou C, Xiao M, Cheng S, Lu X, Jia S, Ren Y
and Li Z: miR-485-3p and miR-485-5p suppress breast cancer cell
metastasis by inhibiting PGC-1α expression. Cell Death Dis.
7:e21592016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B,
Wang C, Chen T, Tu K and Liu Q: Long non-coding RNA DSCR8 acts as a
molecular sponge for miR-485-5p to activate Wnt/β-catenin signal
pathway in hepatocellular carcinoma. Cell Death Dis. 9:8512018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ou R, Lv J, Zhang Q, Lin F, Zhu L, Huang
F, Li X, Li T, Zhao L, Ren Y and Xu Y: circAMOTL1 Motivates AMOTL1
expression to facilitate cervical cancer growth. Mol Ther Nucleic
Acids. 19:50–60. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu J, Li J, Ren J and Zhang D:
MicroRNA-485-5p represses melanoma cell invasion and proliferation
by suppressing Frizzled7. Biomed Pharmacother. 90:303–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang RS, Zheng YL, Li C, Ding C, Xu C and
Zhao J: MicroRNA-485-5p suppresses growth and metastasis in
non-small cell lung cancer cells by targeting IGF2BP2. Life Sci.
199:104–111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Hu J, Zhou W and Gao H: LncRNA
FOXD2-AS1 accelerates the papillary thyroid cancer progression
through regulating the miR-485-5p/KLK7 axis. J Cell Biochem.
2018.(Epub ahead of print).
|
|
26
|
Duan J, Zhang H, Li S, Wang X, Yang H,
Jiao S and Ba Y: The role of miR-485-5p/NUDT1 axis in gastric
cancer. Cancer Cell Int. 17:922017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chai Y, Du Y, Zhang S, Xiao J, Luo Z, He F
and Huang K: MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and
inhibits colorectal cancer proliferation. Exp Cell Res.
368:111–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin XJ, He CL, Sun T, Duan XJ, Sun Y and
Xiong SJ: hsa-miR-485-5p reverses epithelial to mesenchymal
transition and promotes cisplatin-induced cell death by targeting
PAK1 in oral tongue squamous cell carcinoma. Int J Mol Med.
40:83–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han DL, Wang LL, Zhang GF, Yang WF, Chai
J, Lin HM, Fu Z and Yu JM: MiRNA-485-5p, inhibits esophageal cancer
cells proliferation and invasion by down-regulating O-linked
N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci.
23:2809–2816. 2019.PubMed/NCBI
|
|
30
|
Wang FR, Xu SH, Wang BM and Wang F:
miR-485-5p inhibits metastasis and proliferation of osteosarcoma by
targeting CX3CL1. Eur Rev Med Pharmacol Sci. 22:7197–7204.
2018.PubMed/NCBI
|
|
31
|
Gao F, Wu H, Wang R, Guo Y, Zhang Z, Wang
T, Zhang G, Liu C and Liu J: MicroRNA-485-5p suppresses the
proliferation, migration and invasion of small cell lung cancer
cells by targeting flotillin-2. Bioengineered. 10:1–12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Jiang Y, Wan Y, Zhang L, Qiu J,
Zhou S and Cheng W: UCA1 functions as a competing endogenous RNA to
suppress epithelial ovarian cancer metastasis. Tumour Biol.
37:10633–10641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang W, Han L, Xing P, Xing P, Liu B, Sun
Z, Zhou W and Dong J: LncRNA RHPN1-AS1 accelerates proliferation,
migration, and invasion via regulating miR-485-5p/BSG axis in
hepatocellular carcinoma. Naunyn Schmiedebergs Arch Pharmacol.
393:2543–2551. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Yan Z, Wang L, Zhang S and Gao M:
STAT1-induced upregulation of lncRNA RHPN1-AS1 predicts a poor
prognosis of hepatocellular carcinoma and contributes to tumor
progression via the miR-485/CDCA5 axis. J Cell Biochem. 2020.(Epub
ahead of print).
|
|
35
|
Wittmann T, Boleti H, Antony C, Karsenti E
and Vernos I: Localization of the kinesin-like protein Xklp2 to
spindle poles requires a leucine zipper, a microtubule-associated
protein, and dynein. J Cell Biol. 143:673–685. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gruss OJ and Vernos I: The mechanism of
spindle assembly: Functions of Ran and its target TPX2. J Cell
Biol. 166:949–955. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stewart S and Fang G: Anaphase-promoting
complex/cyclosome controls the stability of TPX2 during mitotic
exit. Mol Cell Biol. 25:10516–10527. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Warner SL, Stephens BJ, Nwokenkwo S,
Hostetter G, Sugeng A, Hidalgo M, Trent JM, Han H and Von Hoff DD:
Validation of TPX2 as a potential therapeutic target in pancreatic
cancer cells. Clin Cancer Res. 15:6519–6528. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tonon G, Wong KK, Maulik G, Brennan C,
Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, et
al: High-resolution genomic profiles of human lung cancer. Proc
Natl Acad Sci USA. 102:9625–9630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Smith LT, Mayerson J, Nowak NJ, Suster D,
Mohammed N, Long S, Auer H, Jones S, McKeegan C, Young G, et al:
20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH,
and association with outcome. Genes Chromosomes Cancer. 45:957–966.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wei P, Zhang N, Xu Y, Li X, Shi D, Wang Y,
Li D and Cai S: TPX2 is a novel prognostic marker for the growth
and metastasis of colon cancer. J Transl Med. 11:3132013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song T, Xu A, Zhang Z, Gao F, Zhao L, Chen
X, Gao J and Kong X: CircRNA hsa_circRNA_101996 increases cervical
cancer proliferation and invasion through activating TPX2
expression by restraining miR-8075. J Cell Physiol.
234:14296–14305. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yan L, Li Q, Yang J and Qiao B:
TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation,
invasion, and tumor growth of bladder cancer. J Cell Biochem.
119:1791–1803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tian Y, Liu LL, Guo DM, Wang Y, Zha WH, Li
Y and Wu FJ: TPX2 gene silencing inhibits cell proliferation and
promotes apoptosis through negative regulation of AKT signaling
pathway in ovarian cancer. J Cell Biochem. 119:7540–7555. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Taherdangkoo K, Kazemi Nezhad SR, Hajjari
MR and Tahmasebi Birgani M: miR-485-3p suppresses colorectal cancer
via targeting TPX2. Bratisl Lek Listy. 121:302–307. 2020.PubMed/NCBI
|
|
46
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma S, Rong X, Gao F, Yang Y and Wei L:
TPX2 promotes cell proliferation and migration via PLK1 in OC.
Cancer Biomark. 22:443–451. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang D, Chen J, Yang C and Wang M: TPX2
silencing mediated by joint action of microvesicles and ultrasonic
radiation inhibits the migration and invasion of SKOV3 cells. Mol
Med Rep. 17:7627–7635. 2018.PubMed/NCBI
|
|
50
|
Zhao J, Yang T, Ji J, Zhao F, Li C and Han
X: RHPN1-AS1 promotes cell proliferation and migration via
miR-665/Akt3 in ovarian cancer. Cancer Gene Ther. 28:33–41. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang J, Ding W, Xu Y, Tao E, Mo M, Xu W,
Cai X, Chen X, Yuan J and Wu X: Long non-coding RNA RHPN1-AS1
promotes tumorigenesis and metastasis of ovarian cancer by acting
as a ceRNA against miR-596 and upregulating LETM1. Aging (Albany
NY). 12:4558–4572. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhu P, Li Y, Li P, Zhang Y and Wang X:
c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on
breast cancer cell proliferation via inhibiting P53. Mol Genet
Genomics. 294:1219–1229. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liang D, Liu H, Yang Q, He Y, Yan Y, Li N
and You W: Long noncoding RNA RHPN1-AS1, induced by KDM5B, is
involved in breast cancer via sponging miR-6884-5p. J Cell Biochem.
2020.(Epub ahead of print). View Article : Google Scholar
|
|
54
|
Huang S, Zou C, Tang Y, Wa Q, Peng X, Chen
X, Yang C, Ren D, Huang Y, Liao Z, et al: miR-582-3p and miR-582-5p
suppress prostate cancer metastasis to bone by repressing TGF-β
Signaling. Mol Ther Nucleic Acids. 16:91–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Morgan-Lappe SE, Tucker LA, Huang X, Zhang
Q, Sarthy AV, Zakula D, Vernetti L, Schurdak M, Wang J and Fesik
SW: Identification of Ras-related nuclear protein, targeting
protein for xenopus kinesin-like protein 2, and stearoyl-CoA
desaturase 1 as promising cancer targets from an RNAi-based screen.
Cancer Res. 67:4390–4398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liang B, Zheng W, Fang L, Wu L, Zhou F,
Yin X, Yu X and Zou Z: Overexpressed targeting protein for Xklp2
(TPX2) serves as a promising prognostic marker and therapeutic
target for gastric cancer. Cancer Biol Ther. 17:824–832. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chang H, Wang J, Tian Y, Xu J, Gou X and
Cheng J: The TPX2 gene is a promising diagnostic and therapeutic
target for cervical cancer. Oncol Rep. 27:1353–1359.
2012.PubMed/NCBI
|
